- Country: Estonia
- Summary: Anti -Tumor Agents, Endocrinological Treatment, Immunostimulators, Immunosupers, Diagnostic Agents, all other Therapeutic Agents, other Systemic Haemostatic Agents
- EET Ref No: 121902307
- Deadline: 08 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 595000.00
- Notice Type: Tender
- Document Ref. No.: 427667-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase of anti -tumor, endocrinological therapy, immunostimulators, immunosupers, diagnostic agents, all other therapeutic agents, other system -embracing haemostatic substances and the bases for elimination and qualify
Cyclophosphamide
Drug Buying / Eliminating Cyclophosphamide with active ingredient Cyclophosphamide: View Procurement Basic Documents
Melfalan
Melfalan Purchase / Elimination Basics and Qualifying Terms and Conditions: View Procurement Basic Documents
Ifosfamide
Purchase of Ifosfamide with the active ingredient in the drug / Fundamentals and Conditions of Eliminating: See the Procurement Basic Documents
Bendamustin
Bendamustin Purchase / Removal Basics and Qualifying Terms and Conditions: View Procurement Basic Documents
Thiotepa
Purchase of / Elimination Basics and Qualification Terms and Conditions with the active ingredient in the drug: See the source documents of the procurement
Harsh
Purchase / Questionnaire with the active ingredient of the drug with the active ingredient: see the source documents of the procurement
Lomustin
Purchase / Questionnairment of the active ingredient with the active ingredient in the drug: See the source documents of the procurement
Methotrexate
Drug Methotrexate with active ingredient purchase / bases for elimination and qualifying conditions: See the source documents of the procurement
Pemetrex
Buying / Eliminating Basics and Conditions of Petrexes with the active ingredient of the drug: View Procurement Basic Documents
Cladribin
Drug toi... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAnti -Tumor Agents, Endocrinological Treatment, Immunostimulators, Immunosupers, Diagnostic Agents, all other Therapeutic Agents, other Systemic Haemostatic Agents - Estonia Tender
The FOUNDATION NORTH ESTONIAN REGIONAL HOSPITAL, a Government sector organization in Estonia, has announced a new tender for Anti -Tumor Agents, Endocrinological Treatment, Immunostimulators, Immunosupers, Diagnostic Agents, all other Therapeutic Agents, other Systemic Haemostatic Agents. This tender is published on EstoniaTenders under EET Ref No: 121902307 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-08.
The estimated tender value is EUR 595000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
